Marketwire - Specialty Chemicals

Methanex to Present at Goldman Sachs Basic Materials Conference

Thu, 15 May 2008 17:02:00 EDT

VANCOUVER, BRITISH COLUMBIA--(Marketwire - May 15, 2008) - Methanex Corporation (TSX:MX)(NASDAQ:MEOH)(SANTIAGO:Methanex) will be presenting at the upcoming Goldman Sachs Basic Materials Conference being held May 20-22, 2008 in New York City. Mr. Ian Cameron, Methanex's Senior Vice-President, Finance and Chief Financial Officer, will speak to investors on Thursday, May 22, 2008 at approximately 11:45 a.m. ET (8:45 a.m. PT). Interested participants can access a live audio webcast of the presentation through the Company's website at http://www.methanex.com/investor/events.html. The webcast will last for approximately 30 minutes. In addition, an audio recording of the presentation can be downloaded from our website for three weeks after the conference.

RAE Systems to Present at Three Investor Conferences

Thu, 15 May 2008 16:48:00 EDT

SAN JOSE, CA--(Marketwire - May 15, 2008) - RAE Systems Inc. (AMEX: RAE), a leading global provider of rapidly deployable sensor networks that enable customers to identify safety and security threats in real time, announced that management will present at three investor conferences in May.

--  May 20 at the Brean Murray All Cap All China Investor Conference being
    held at the Waldorf Astoria Hotel in New York, NY. The presentation will be
    webcast at 2:00 p.m. ET and can be retrieved at
    http://www.wsw.com/webcast/bmry3/rae/
--  May 21 at the Barrington Industrial Growth Investor Conference being
    held at the Chicago Hilton Hotel in Chicago, IL
--  May 28 at the Morgan Keegan Homeland Security Technology Investor
    Conference being held at the Waldorf Astoria in New York, NY.  The
    presentation will be webcast at 1:30 p.m. ET on May 28 and can

AirBoss of America Corp. Declares Dividend

Thu, 15 May 2008 16:40:00 EDT

NEWMARKET, ONTARIO--(Marketwire - May 15, 2008) - Mr. Gren Schoch, Chairman of the Board of AirBoss of America Corp. (TSX:BOS) is pleased to announce that the Board of Directors has approved a dividend of $0.025 per common share to be paid July 24, 2008 to shareholders of record at June 30, 2008. AirBoss of America Corp. develops, manufactures, and sells high quality, proprietary rubber-based products offering enhanced performance and productivity to transportation, military and industrial markets. With a capacity to supply over 250 million pounds of rubber annually to a diverse group of rubber manufacturers, AirBoss is also one of North America's largest custom rubber compounding companies. The Company's shares trade on the TSX under the symbol BOS. Visit www.airbossofamerica.com.

Airboss Awarded Gas Mask Contract May 15, 2008

Thu, 15 May 2008 16:30:00 EDT

Announcement of prospectus regarding rights issue in Active Biotech AB (publ)

Thu, 15 May 2008 07:38:00 EDT

LUND, SWEDEN--(Marketwire - May 15, 2008) - The Swedish language prospectus regarding the rights issue in Active Biotech AB (publ) is now available at the company's website www.activebiotech.com and at the company's main office, address Scheelev�gen 22, SE-220 07, Lund, Sweden. The prospectus may also be obtained from the company via telephone, +46-46 19 20 00. Documents incorporated by reference in the prospectus are also available in accordance with the above.

CAPITAL MARKETS DAY - PRESENTATIONS PART 3

Thu, 15 May 2008 06:21:00 EDT

LYSAKER, NORWAY--(Marketwire - May 15, 2008) -

Please find enclosed part 3 of the presntations used during Pronova BioPharma's Capital Markets Day 15 May 2008. The presentations can also be downloaded from www.pronova.com

Omacor_Lovaza franchise potential: http://hugin.info/137506/R/1219433/255905.pdf

For further information, please contact:
Pronova BioPharma:
Tomas Settevik, CEO +47 22 53 48 61
Solveig Hellebust, Vice President HR &
Communications +47 22 53 48 94
Hilde Steineger, Head of IR +47 48 00 42 40

Financial Dynamics:
David Yates / Lara Mott +44 207 269 7182

CAPITAL MARKETS DAY - PRESENTATIONS PART 2

Thu, 15 May 2008 06:20:00 EDT

LYSAKER, NORWAY--(Marketwire - May 15, 2008) -

Please find enclosed part 2 of the presntations used during Pronova BioPharma's Capital Markets Day 15 May 2008. The presentations can also be downloaded from www.pronova.com

Medical affairs: http://hugin.info/137506/R/1219431/255900.pdf

Heart failure: http://hugin.info/137506/R/1219431/255901.pdf

CAPITAL MARKETS DAY - PRESENTATIONS PART 1

Thu, 15 May 2008 06:15:00 EDT

LYSAKER, NORWAY--(Marketwire - May 15, 2008) -

Please find attached part 1 of the presentations used during Pronova BioPharma's Capital Markets Day 15 May 2008. The presentations can also be downloaded from the company`s web site www.pronova.com.

Manufacturing: http://hugin.info/137506/R/1219428/255891.pdf

Markets and partners: http://hugin.info/137506/R/1219428/255893.pdf

Western Canada Continues to Invest in Its Future as a Petrochemical Hub of the North, an Industrial Info News Alert

Thu, 15 May 2008 05:00:00 EDT

SUGAR LAND, TX--(Marketwire - May 15, 2008) - Researched by Industrial Info Resources (Sugar Land, Texas) -- The western provinces of Canada, including Alberta, British Columbia, Manitoba, Saskatchewan, the Yukon Territory and the Northwest Territories, have consistently invested largely in new capacity projects and expansions in the Chemical Processing Industry (CPI) during recent years. Alberta, British Columbia and Saskatchewan have been the focus for much of this spending, as they are home to the largest portion of the nearly 100 CPI plants operating in the region.

Learn about the World Oxalic Acid Markets

Thu, 15 May 2008 05:00:00 EDT

LONDON, UNITED KINGDOM--(Marketwire - May 15, 2008) - Reportlinker.com announces that a new market research report related to the Chemicals industry is available in its catalogue.

World Oxalic Acid Markets

http://www.reportlinker.com/p087277/World-Oxalic-Acid-Markets.html

This report analyzes the worldwide markets for Oxalic Acid in Tons. The specific end-use segments discussed are Pharmaceuticals, Rare Earth Products, Fine Chemicals, Printing & Dyeing Light Industrial Goods and Textiles, Daily Use Chemicals, and Others. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. Annual forecasts are provided for each region for the period of 2001 through 2015. A ten-year historic analysis is also provided for these markets with annua

Active Biotech to Present at the Rodman & Renshaw 5th Annual Global Healthcare Conference

Thu, 15 May 2008 04:21:00 EDT

LUND, SWEDEN--(Marketwire - May 15, 2008) - Lund, Sweden - 15 May 2008 - Active Biotech (OMX Nordic: ACTI) management is scheduled to present at the Rodman & Renshaw Annual Global Healthcare Conference next week at 10:00 AM CEST on Tuesday, 20 May at Le Meridien Beach Plaza Hotel, Monte Carlo, Monaco. During the presentation, an update will be provided on the Active Biotech development program.

The company has five projects in clinical development for the treatment of serious autoimmune/inflammatory diseases and cancer. Laquinimod - a novel oral treatment of multiple sclerosis - is developed through a cooperation with Teva Pharmaceutical Industries Ltd and is currently in Phase III global clinical trials in US, Europe and Israel with approximately 2 200 patients. ANYARA - a novel cancer targeted therapy - is in Phase III trials with 500 advanced renal cell cancer patients. Further key projects in clinical development comprise thre

OctoPlus to hold Extraordinary General Meeting of Shareholders on 30 May

Thu, 15 May 2008 01:50:00 EDT

LEIDEN, NETHERLANDS--(Marketwire - May 15, 2008) -

Meeting to extend period for preparation of 2007 annual accounts

OctoPlus N.V. ("OctoPlus" or the "Company") (Euronext: OCTO), the drug delivery and development company, announces today that it will hold an Extraordinary General Meeting of Shareholders (the "Meeting") on 30 May 2008 at the Company's headquarters in Leiden, in order to extend the period for preparation of its annual accounts for the year 2007 with a maximum of 6 months, until 30 November 2008.

Interim Report: UCB off to a good start in 2008

Thu, 15 May 2008 01:13:00 EDT

BRUSSELS, BELGIUM--(Marketwire - May 15, 2008) -

  * Financial performance in-line with expectations
  * UCB's pipeline is progressing well

Brussels/Belgium, May 15, 2008 at 7:00 am CET - UCB announced today that the financial performance of the UCB Group in the first three months of 2008 was in-line with expectations.

"In the first three months of 2008, UCB made significant progress and achieved important milestones executing our strategy. In April, we launched Cimzia� in the United States for the treatment of Crohn's disease, less than 48 hours following the FDA's approval," comments Roch Doliveux, CEO of UCB. "On the other hand, in March we had to announce a recall of Neupro� and an out-of-stock situation in the United States. This issue had only limited impact to the financial performance of the UCB Group in the first three months of 2008. Overall, in the first quarter, we achieved a financial performance well in line with our stated expec

Elevance, a Recently Formed Renewable Chemicals Company, to Spearhead Stellar Line-Up at GreenTech 2008

Wed, 14 May 2008 20:14:00 EDT

Experts to Address Worldwide Demand for New Energy Sources and Renewable Products June 6, Pasadena Hilton

CCR Technologies Ltd. Reports First Quarter 2008 Results

Wed, 14 May 2008 18:58:00 EDT

CALGARY, ALBERTA--(Marketwire - May 14, 2008) - CCR Technologies Ltd. (TSX:CRL) (the "Corporation") (www.reclaim.com), a leading chemical purification technology solutions and service provider, today announced financial results for the period ended March 31, 2008. For the three months ended March 31, 2008, the Corporation reported revenue of $1,251,000 resulting in a net loss of $1,296,000 as compared to revenue of $1,553,344 and a net loss of $1,624,000 for the same period in 2007. Complete details of the Corporation's annual financial and related information are available on SEDAR at www.sedar.com.

Hartindo AF21 Fire Inhibitor, Combined With WoodSmart's BluWood(R), to Be Used in New Home That Will Replace House Lost in Tragic 2007 California Fires

Wed, 14 May 2008 16:00:00 EDT

BRENTWOOD, TN--(Marketwire - May 14, 2008) - MSE Enviro-Tech Corp. (PINKSHEETS: MEVT) and (FRANKFURT: MEH), in conjunction with Megola Inc. (PINKSHEETS: MGOA), are pleased to announce that their Hartindo AF21 Fire Inhibitor and Woodsmart Solution's BluWood� product combination has been selected for use in a new home being constructed to replace a house lost in the record-setting fires of 2007 in southern California.

DuPont Finalizing Installation of Purification Unit at Tennessee Titanium Dioxide Plant, an Industrial Info News Alert

Wed, 14 May 2008 06:30:00 EDT

SUGAR LAND, TX--(Marketwire - May 14, 2008) - Researched by Industrial Info Resources (Sugar Land, Texas) -- E.I. DuPont de Nemours & Company (NYSE:DD) (DuPont) (Wilmington, Delaware) is finalizing the installation of a new $30 million purification unit at its New Johnsonville, Tennessee, titanium dioxide plant. The unit will produce an estimated 100 million pounds per year of high-purity titanium tetrachloride.

For details, view the entire article by subscribing to Industrial Info's Premium Industry News at http://www.industrialinfo.com/showNews.jsp?newsitemID=132744, or browse other breaking industrial news stories at www.industrialinfo.com.

Potash One Reports Historical Data on New Permits

Wed, 14 May 2008 06:00:00 EDT

VANCOUVER, BRITISH COLUMBIA--(Marketwire - May 14, 2008) - Potash One Inc. (the "Company" or "Potash One") (TSX VENTURE:KCL) is pleased to report the results of a preliminary review of existing historical data on the newly acquired permits KP-355, KP-356 and KP-357, (NR08-13, April 11,2008) located in southern Saskatchewan and adjacent to the largest solution potash mine in the world. Preliminary data obtained from commercial databases and files held by the Saskatchewan Ministry of Energy and Resources indicates that previous exploratory drilling has been conducted on the newly acquired ground, and limited examination indicates that all three potash-bearing Members are present in varying thicknesses, grade and distribution within the Prairie Evaporite Basin.

QIAGEN and GENEART Partner to Commercialize Synthetic Human Genes

Wed, 14 May 2008 02:00:00 EDT

VENLO, NETHERLANDS--(Marketwire - May 14, 2008) -

Joint development and collaboration enables enhanced production of every human protein, spurring advances in drug development

Venlo, The Netherlands --- May 14, 2008 - QIAGEN (Nasdaq: QGEN; Frankfurt, Prime Standard: QIA) and GENEART (Frankfurt, Entry Standard, G6A) announced their collaboration to develop, produce and commercialize a new product line for the enhanced production of all 35,000 human proteins. QIAgenes is the world's first comprehensive set of plasmids (small extra-chromosomal DNA molecules in bacteria) which serve as carriers ("vectors") for modified ("optimized") synthetic genes mapping the entire human genome. By using the QIAgenes set of plasmids and optimized genes for synthetic protein production in bacteria, academic and biomedical researchers, as well as biotech and pharmaceutical companies can more easily produce large amounts of proteins which play key roles in diseases such as cancer and th

AgraQuest Inc. nombra como director ejecutivo a Marcus Meadows-Smith

Tue, 13 May 2008 19:12:00 EDT

Meadows-Smith liderar� la empresa de protecci�n de cosechas hacia la siguiente etapa de su crecimiento global

Potash One Subscribes for Equity of New Saskatchewan Potash Junior

Tue, 13 May 2008 14:41:00 EDT

VANCOUVER, BRITISH COLUMBIA--(Marketwire - May 13, 2008) - Potash One Inc. (the "Company" or "Potash One") (TSX VENTURE:KCL) is pleased to confirm that the two potash permit applications (KP 416 and KP 417) sold by the Company to 0821474 B.C. Ltd. ("Numberco"), a subsidiary of Peninsula Merchant Syndications Corp. ("Peninsula"), a private company at arms length to the Company and its directors and officers, have been sold by Peninsula to Timer Explorations Inc. ("Timer"), a reporting issuer in British Columbia whose common shares are listed on the TSX Venture Exchange and which is also at arms length to the Company and its directors and officers. To acquire the permits, Timer will purchase all of the outstanding shares of Numberco. This acquisition by Timer is part of a larger transaction pursuant to which Timer will also complete (i) a subdivision of its shares on a 2 new shares for 1 old share basis, (ii) an $8.4 million private placement of units at a price of $0.35 per unit, each

AgraQuest Inc. indica Marcus Meadows-Smith como CEO

Tue, 13 May 2008 11:34:00 EDT

Meadows-Smith dever� liderar a firma de prote��o de safra em sua pr�xima fase de crescimento global

Migao Corporation Revises Time for Second Quarter Financial Results Conference Call

Tue, 13 May 2008 09:29:00 EDT

TORONTO, ONTARIO--(Marketwire - May 13, 2008) - Migao Corporation (TSX:MGO) has revised the time of the previously announced conference call to discuss the Company's second quarter financial results for the period ending March 31, 2008. Migao apologizes for any inconvenience as a result of the rescheduled time. Mr. Lui Guocai, CEO, Paul Haber, CFO, and Jay Hussey, V.P. Corporate Finance will be hosting the call. Migao will be issuing a press release announcing the second quarter results pre-market open on Tuesday May 13, 2008.

Migao Announces Second Quarter Financial Results

Tue, 13 May 2008 08:34:00 EDT

- Gross Profit Margin Improves to 24% - - Keith Attoe to Re-Join Board of Directors -

Kenneth Boyda Named to Ahura Scientific, Inc. Board of Directors

Tue, 13 May 2008 08:30:00 EDT

Former General Electric Executive Brings Wealth of Security Experience and Operational Excellence to Growing and Innovative Company

Symyx Speeds Adoption of Symyx Notebook and Other Software Products Through Convenient, Cost-Effective Online Training

Tue, 13 May 2008 08:00:00 EDT

SANTA CLARA, CA--(Marketwire - May 13, 2008) - To help scientists achieve maximum benefit from Symyx software, Symyx Technologies, Inc. (NASDAQ: SMMX) has extended its eLearning service (Symyx Learning on Demand) to support Symyx Notebook, the new, enterprise Electronic Laboratory Notebook (ELN) that is adaptable to meet the needs of multiple scientific disciplines. With the Learning on Demand service, scientists can obtain 'anytime-anywhere' training on how to plan, document and analyze experiments effectively in the Symyx Notebook environment.

Active Biotech advances ANYARA into Phase III clinical trial

Tue, 13 May 2008 02:41:00 EDT

LUND, SWEDEN--(Marketwire - May 13, 2008) - Lund, Sweden, May 13, 2008 - An interim analysis has been performed in Active Biotech AB's (OMX Nordic: ACTI) ongoing Phase II/III clinical study of ANYARA, in patients with advanced renal cell cancer.

Active Biotech advances ANYARA into Phase III clinical trial -- http://hugin.info/1002/R/1218474/255317.pdf

Crucell Announces First Quarter 2008 Results

Tue, 13 May 2008 02:19:00 EDT

LEIDEN, NETHERLANDS--(Marketwire - May 13, 2008) -

Total revenue and other operating income of EUR 47.9 million, showing 36% growth in the first quarter of 2008 compared to EUR 35.2 million in the same period of 2007.

Net loss in the quarter halved to EUR 9.0 million compared to Q107.

New contracts awarded for QuinvaxemT and strong sales in travel vaccines drive autonomous growth.

Gross margin in the first quarter improved to 40% up from 23% last year.

2008 full year guidance reiterated: total revenue and other operating income growth of 20% in constant currencies ; higher margins; positive cash flow.

Start of Phase II Clinical Study for Rabies Monoclonal Antibody Combination in the Philippines

Tue, 13 May 2008 01:58:00 EDT

LEIDEN, NETHERLANDS--(Marketwire - May 13, 2008) - Dutch biotechnology company Crucell N.V. today announced that its rabies monoclonal antibody combination product has entered a second phase II clinical study in the Philippines. On 31 March 2008 the company announced the start of a first phase II clinical study in the U.S.

At the beginning of the year, Crucell announced a collaboration and commercialization agreement with sanofi pasteur for Crucell's rabies monoclonal antibody combination product to be used in combination with rabies vaccines for post-exposure prophylaxis against this fatal disease. Crucell received an initial payment of EUR 10 million following the execution of the agreement and will be eligible for milestone payments of up to EUR 66.5 million. The first phase II study, as announced in March 2008, marked an important milestone in the collaboration agreement.

SR3 Single Piece CBRN Body Armor Delivers New Ease of Use

Tue, 13 May 2008 00:00:00 EDT

Remploy Frontline's Single Piece Garment Reduces Suit Weight by 38%

AgraQuest Inc. Names Marcus Meadows-Smith CEO

Mon, 12 May 2008 20:05:00 EDT

Meadows-Smith to Lead Crop Protection Firm Through Next Phase of Global Growth

AirBoss Announces 1st Quarter 2008 Results

Mon, 12 May 2008 16:30:00 EDT

NEWMARKET, ONTARIO--(Marketwire - May 12, 2008) - AirBoss of America Corp. ("AirBoss") (TSX:BOS) announces the following results for the three month period ended March 31, 2008: /T/ Three months ended March 31 (thousand $CAD, except shares and per share amounts) 2008 2007 -------------------------------------------------------------------------- N

AgriTec Systems Announces USD $16,000 Private Placement

Mon, 12 May 2008 15:12:00 EDT

WEBSTER, TEXAS--(Marketwire - May 12, 2008) - AgriTec Systems Inc. (TSX VENTURE:AGR) ("AgriTec" or the "Corporation") is pleased to announce that it has entered into agreements with one arm's length party, who has agreed to purchase an aggregate of 16,000 Series A Preferred Shares at US $1.00 from the treasury of the Corporation, for gross proceeds to AgriTec of US $16,000. Each Series A Preferred Share shall be entitled to receive a cumulative dividend at the rate of 7% per annum, is redeemable at the option of AgriTec and is convertible into 3 listed Common Shares of the Corporation for a period of five years. The placement was completed on a non-brokered basis, and no commissions or finder's fees are payable in connection with the transaction. Proceeds of the placement will be used for general working capital for the Corporation. The required documentation is being filed with the TSX Venture Exchange, and completion of the private placement is pending regulatory approval.

Canexus Announces May Distribution

Mon, 12 May 2008 11:14:00 EDT

CALGARY, ALBERTA--(Marketwire - May 12, 2008) - Canexus Income Fund (TSX:CUS.UN) (the "Fund") today announced the cash distribution for the period May 1, 2008, to May 31 2008, has been set at $0.0456 per unit. The distribution will be paid on or about June 15, 2008, to unitholders of record as at May 30, 2008. This payment is consistent with the Fund's distribution policy. The Fund has a Distribution Reinvestment Plan ("DRIP") that enables participants to automatically reinvest monthly distributions in additional trust units of the Fund. More information on the DRIP is available on the Canexus website at www.canexus.ca.

Sinopec Completes 100,000-Ton Butadiene Factory, an Industrial Info News Alert

Mon, 12 May 2008 07:00:00 EDT

BEIJING--(Marketwire - May 12, 2008) - Researched by Industrial Info Resources (Sugar Land, Texas) -- Sinopec (NYSE:SNP) recently announced that its new 100,000-ton-per-annum (TPA) butadiene factory has started its trial run. The factory is a part of Yangtze Petrochemical Company (YPC) (Nanjing City), a subsidiary of Sinopec.

For details, view the entire article by subscribing to Industrial Info's Premium Industry News at http://www.industrialinfo.com/showNews.jsp?newsitemID=132679, or browse other breaking industrial news stories at www.industrialinfo.com.

Pacific Sands 'Natural Choices' Line Offers the Largest Selection of Oxygen Bleach Based Products for Private Label & Custom Formulation

Fri, 09 May 2008 09:01:00 EDT

Company Targets Untapped Private Label Arena for Its Environmentally Friendly, Chlorine-Free Product Line

Spending for Agricultural Chemicals and Fertilizers Increases Momentum

Fri, 09 May 2008 07:01:00 EDT

SUGAR LAND, TX--(Marketwire - May 9, 2008) - Researched by Industrial Info Resources (Sugar Land, Texas) -- Earlier this year, Industrial Info reported tracking nearly $370 million in future capital and maintenance spending in the agricultural chemicals segment of the Chemical Processing Industry in the United States and Canada. That number has soared over the last few months, reaching an estimated $570 million with several large new projects identified by Industrial Info as part of its North American Project Database.

MoneyTV, Week of 5/9

Fri, 09 May 2008 05:00:00 EDT

LOS ANGELES, CA--(Marketwire - May 9, 2008) - MoneyTV is the nationally syndicated television program all about money and what makes it happen (http://www.moneytv.net), featuring informative interviews by hosts Donald Baillargeon and Skip Lindeman with company CEOs, providing insights into their operations and outlooks for their futures.

Free information packages from the featured companies can be requested by sending an email to info@moneytv.net.

DSM - Repurchase of shares (week 19)

Fri, 09 May 2008 03:20:00 EDT

HEERLEN, NETHERLANDS--(Marketwire - May 9, 2008) -

Royal DSM N.V. has repurchased 298,333 of its own shares in the period from 5 May 2008 up to and including 7 May 2008 at an average price of EUR 35.46. This is in accordance with the second phase of the share buyback program, announced on 5 May 2008. The consideration of this repurchase was EUR 10.6 million.

DSM - the Life Sciences and Materials Sciences Company

Royal DSM N.V. creates innovative products and services in Life Sciences and Materials Sciences that contribute to the quality of life. DSM's products and services are used globally in a wide range of markets and applications, supporting a healthier, more sustainable and more enjoyable way of life. End markets include human and animal nutrition and health, personal care, pharmaceuticals, automotive, coatings and paint, electrics and electronics, life protection and housing. DSM has annual sales of almost EUR 8.8 billion and employs some 23,000 people worldwi